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Background: Salmonellosis and shigellosis are mandatorily notifiable diseases in Greece. Underreporting of both
diseases has been postulated but there has not been any national study to quantify it. The objective of this study
was to: a) estimate underreporting of hospitalised cases at public Greek hospitals in 2011 with a capture-recapture
(C-RC) study, b) evaluate the accuracy of this estimation, c) investigate the possible impact of specific factors on
notification rates, and d) estimate community incidence of both diseases.
Methods: The mandatory notification system database and the database of the National Reference Laboratory for
Salmonella and Shigella (NRLSS) were used in the C-RC study. The estimated total number of cases was compared
with the actual number found by using the hospital records of the microbiological laboratories. Underreporting was
also estimated by patients’ age-group, sex, type of hospital, region and month of notification. Assessment of the
community incidence was based on the extrapolation of the hospitalisation rate of the diseases in Europe.
Results: The estimated underreporting of salmonellosis and shigellosis cases through the C-RC study was 47.7%
and 52.0%, respectively. The reporting rate of salmonellosis significantly varied between the thirteen regions of the
country from 8.3% to 95.6% (median: 28.4%). Age and sex were not related to the probability of reporting. The
notification rate did not significantly differ between urban and rural areas, however, large university hospitals had a
higher underreporting rate than district hospitals (p-value < 0.001). The actual underreporting, based on the hospital
records review, was close to the estimated via the C-RC study; 52.8% for salmonellosis and 58.4% for shigellosis. The
predicted community incidence of salmonellosis ranged from 312 to 936 and of shigellosis from 35 to 104 cases
per 100,000 population.
Conclusions: Underreporting was higher than that reported by other countries and factors associated with
underreporting should be further explored. C-RC analysis seems to be a useful tool for the assessment of the
underreporting of hospitalised cases. National data on underreporting and under-ascertainment rate are needed for
assessing the accuracy of the estimation of the community burden of the diseases.
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Figure 1 Schematic description of the distribution of the total
number of cases in a two-source capture-recapture model
(Venn diagram). n is the total number of cases in the population,
L1 and L2 the number of cases captured by each one of the two
systems, m the number of missing cases from both systems and d
the duplicates.
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Salmonellosis and shigellosis are included in the list of the
45 mandatory notifiable diseases in Greece. Salmonellosis
is one of the most frequently reported diseases of the
Mandatory Notification System (MNS) even though the
notification rate has gradually decreased from 12 cases
per 100,000 population in 2004 to 3.6 cases per 100,000
population in 2012 [1]. The notification rate of shigellosis
has been quite stable during the same period (8 cases per
1,000,000 population in 2012) [1].
Based on- the European Centre for Disease Prevention
and Control data (ECDC), the annual reported incidence
for both diseases substantially differs among European
countries [2]. This difference can only partially be attributed
to differences in morbidity among countries and reflects,
to some extent, the different ascertainment and reporting
rates of the diseases [3].
Apart from few, restricted to small geographical areas
of the country, studies [4], no nation-wide study has been
conducted in Greece to estimate completeness of reporting
or external completeness of MNS for salmonellosis and
shigellosis in an objective and measurable way.
The best method to estimate surveillance systems’ com-
pleteness is to use an external data source as a reference
and compare the number of notified cases to the number
of cases included in the reference data source [5]. However,
such a data source that can be used as a “gold standard” is not
always available or accessible and alternative methods, such
as capture-recapture (C-RC) analysis, have been proposed
for estimating underreporting of surveillance systems [6-8].
The core idea of C-RC studies is to sample and identify
cases of a disease in a population and then resample the
population to see what fraction of cases in the second
sample were, also, identified in the first one [9]. In this way,
the fraction of cases not found in neither sample, as well as
the level of underreporting of each data source (or combi-
nations of them) can be calculated. The C-RC method, that
was initially developed to estimate the size of wildlife popu-
lations [10], has been used for estimating underreporting of
chronic diseases, as well as for tuberculosis, meningococcal
disease, and other infectious diseases [11-14].
The objective of this study was to: a) estimate under-
reporting of hospitalised salmonellosis and shigellosis
cases from public Greek hospitals to the MNS in 2011 via
a C-RC study, b) evaluate the accuracy of this estimation,
c) identify factors related to low notification rates in order
to implement the appropriate correction measures for the
improvement of the system, and d) assess the community
incidence of both diseases.
Methods
Capture-recapture study
In Greece, it is mandatory for all physicians, in public
and private sector, to report salmonellosis and shigellosiscases to the local public health authorities and to the
Hellenic Center for Disease Control and Prevention
(HCDCP) via fax. Data entry takes place at HCDCP where
cases are classified according to the 2008 EU definitions
(Commission Decision 2008/426/EC). The notification
form contains the name and demographic characteristics
of cases (sex, date of birth, place of residence), clinical
symptoms, laboratory data and the possible epidemio-
logical link with other cases. In parallel, the serotypes of
salmonellosis and species of shigellosis are monitored via
the National Reference Laboratory for Salmonella and
Shigella (NRLSS) surveillance system. Microbiological
laboratories send isolates to NRLSS accompanied with a
short form that includes the name and demographics
(sex, date of birth, region) of the patient, and the date of
specimen collection. Public hospitals are requested to
send all isolates to NRLSS. In practice, many of the cases
that are reported to MNS are not included in the NRLSS
dataset and vice versa. The schematic description of the
distribution of the total number of cases in a two-source
C-RC model (Venn diagram) is presented in Figure 1.
The conducted C-RC study included all public hospitals
of the country. Private hospitals were excluded since the
number of reported salmonellosis and shigellosis cases by
private hospitals in 2011 was very small (36 and 0 cases,
respectively). Only hospitalised salmonellosis (typhoid and
non-typhoid) and shigellosis cases were included in the
analysis. Probable cases that had been reported to MNS
without laboratory confirmation were excluded.
The datasets from the two systems were retrieved and
data were checked for duplicates. Cases were matched
using the variables “name” and “date of birth”. In those
cases with inconclusive/unclear matching, the hospital
was used as a third matching criterion. Matching was a
continuous process throughout 2011. Data from the NRLSS
were sent to the HCDCP every two weeks and matching
was performed in order to incorporate the laboratory
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were two or more isolates from the same patient in the
database of NRLSS, only the first one was included for the
purposes of this study. Isolates sent to NRLSS from
private sector were excluded.
No special permission for using the data was needed.
HCDCP is the competent authority for surveillance of
communicable diseases according to Greek legislation
and has been officially authorised to receive, treat and
temporarily store personal data of infectious diseases
cases by the Greek Authority for Personal Data Protection.
This study was conducted in the context of the evaluation
of the surveillance system by the Department of Epidemio-
logical Surveillance and Intervention of HCDCP.
Personal data were used only for the purposes of the
evaluation during the matching process. All the necessary
measures to protect the confidentiality of personal data
were taken during the whole process of evaluation (access
to the data restricted to the personnel involved in data
analysis, removal of personal data from the datasets after
matching etc).
The total number of salmonellosis and shigellosis cases
(n) was estimated with Chapman’s formula developed
for two-list C-RC studies [15]:
n ¼ L1þ 1ð Þ L2þ 1ð Þ
d þ 1 −1
95% CI ¼ n 1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
L1þ 1ð Þ L2þ 1ð Þ L1−dð Þ L2−dð Þ
d þ 1ð Þ2 d þ 2ð Þ
s
L1 is the number of cases in the NRLSS dataset, L2
is the number of cases reported to MNS, and d is the
number of cases captured by both systems. Underreporting
to MNS was then estimated. Underreporting rates were
also estimated by geographical region of the country,
month of notification, type of hospital (university/district),
serotype/species patients’ age group (< 5, 5–14, 15–24,
25+ years) and sex.
Hospital registry review
Review of the hospital registries and comparison of data
to the results of the C-RC study was conducted because:
a) a third data source for adjusting calculations was not
available [16,17], b) researchers did not know what kind
of estimations to anticipate since this was the first time
such a study was conducted, and c) only few published
C-RC studies had been conducted on foodborne diseases
[18-20]. During the first semester of 2012, the microbio-
logical laboratories of the public hospitals were asked to
review their registries and count the number of positive
cultures for Salmonella spp. and Shigella spp. in 2011.
An official letter was sent to each hospital explaining therational and the objectives of this review. Only aggregated
data (number of positive stool cultures for Salmonella
spp. and Shigella spp.) were collected and access to the
hospitals’ databases was not needed. The number of
positive cultures was actually the total number of cases
diagnosed and hospitalised during that period. Two or
more positive cultures from the same patient were
considered as only one case. The difference between the
number of positive cultures and the number of reported
cases to MNS represented the missed cases of MNS. The
calculated underreporting rates through hospital registry
review were then compared with the estimated rates from
the C-RC study.
Assessment of the community incidence of salmonellosis
and shigellosis
We assessed/predicted the community incidence of the
diseases in Greece using the percentage of the hospitalised
cases out of the total number of diagnosed salmonellosis
and shigellosis cases (1–3%), based on the results of a
recent European study [21].
Results
Capture-recapture study
Ninety-eight public hospitals that had the capacity to
perform stool cultures were included in the C-RC study.
Nineteen isolates sent to the reference laboratory by
private laboratories and 86 sent by private hospitals
were excluded.
In total, 481 (L1) Salmonella isolates were sent to NRLSS
and 478 (L2) salmonellosis cases were reported to MNS.
The number of matched cases was 251 (d). The estimated
total number of hospitalised salmonellosis cases in 2011
was 915 (95% CI: 861-969). Similarly, the estimated
number for shigellosis was 98 (95% CI: 67-129), since 28
isolates were included in the NRLSS dataset (L1), 47 cases
were reported (L2), and 13 cases were matched (d). The
estimated underreporting of salmonellosis and shigellosis
cases was 47.7% and 52.0%, respectively.
The underreporting rate of salmonellosis to MNS
significantly varied between the thirteen regions of the
country and ranged from 8.3% to 95.6% (median: 28.4%).
Large university hospitals had significantly higher under-
reporting rate than district hospitals (p-value < 0.001). No
specific pattern was identified in the monthly fluctuation
of underreporting. Patients’ age and sex were not associ-
ated with the notification rate of the diseases.
Hospital registry review
Based on the registry review of the 98 hospitals, the
actual number of hospitalised salmonellosis and shigellosis
cases (number of positive stool samples) was 1012 and 113,
respectively, leading to an underreporting of 52.8% for
salmonellosis and 58.4% for shigellosis (Table 1).
Table 1 Underreporting of salmonellosis and shigellosis
hospitalised cases, Greece, 2011
Salmonellosis Shigellosis
Notification
Number of cases–MNS* 478 47
Number of isolates–NRLSS** 481 28
Capture-recapture study
Estimated total number of
cases (95% CI†)
915 (861–969) 98 (67–129)
Estimated underreporting–MNS
(95% CI†)
47.7% (41.8–53.6%) 52.0% (29.8–63.5)
Hospital registry review
Number of diagnosed cases
(positive cultures)
1012 113
Number of cases not reported
to MNS
534 (1012–478) 66 (113–47)
Underreporting-MNS 534/1012 (52.8%) 66/113 (58.4%)
Results of a capture-recapture study and a hospital registry review.
*MNS: Mandatory Notification System.
**NRLSS: National Reference Laboratory for Salmonella spp. and Shigella spp.
† CI: confidence interval.
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and shigellosis
The predicted community incidence of salmonellosis for
2011 ranged from 312 to 936 cases per 100,000 population,
and the incidence of shigellosis ranged from 35 to 104
cases per 100,000 population.
Discussion
The main purpose of public health surveillance is to
provide timely, scientifically sound evidence to stakeholders
and decision makers, in order to make decisions for
improving public health in their jurisdiction [22]. Com-
pleteness of reporting is an important attribute to achieve
this objective. The surveillance system should be appropri-
ately inclusive and the reported cases should also represent
the complete list of eligible persons. In practice, it is a very
challenging task to capture all cases of a disease in the
population; thus, evaluation of completeness is required on
a regular basis [22]. Quantification of underreporting
allows the establishment of a baseline for data quality
and the identification of areas for improvement [5,23]. It,
also, allows comparisons between countries, since diversity
of the health care and surveillance systems handicaps data
comparability.
The estimated reporting rates of salmonellosis and
shigellosis in this study were similar to previous estimations
in the country at a local level [4] and to the estimations of
reporting rates in Spain [24]. Other European countries
have much higher completeness that has been reported to
reach almost 100% when an electronic reporting system is
in place; 95.8% in Sweden [25], 99.0% in Germany [21]
and 82.0% in Italy [21].The estimations of the C-RC study were similar to the
results of the hospital registry review. Authors believe
that the three of the four assumptions of C-RC studies
were not seriously violated; the population was a closed,
well-defined “cohort”, cases of the surveillance systems
were identified and matched, and all cases had the same
probability to be reported to each of the systems (equal
catchability) [16,17]. On the other hand, there might have
been positive dependence between the data leading to an
underestimation of underreporting. In better staffed hospi-
tals, for example, cases that were reported to MNS might
have been more likely to also be found in the NRLSS
dataset [16,17]. However, positive dependence in this case
was quite small as indicated by the comparison with the
results of the registry review.
The results of this study and of similar studies can
be used for better understanding the causes of under-
reporting of the diseases to MNS; for example, reporting
from larger university hospitals may be impaired by the
increased work load of personnel or by the lack of super-
vision and training on reporting processes. Geographical
and seasonal differences, also, need further study. Due to
the small number of reported cases, these parameters could
not be assessed for shigellosis. Low internal completeness
of the variable “serotype” for Salmonella and the variable
“species” for Shigella of the MNS dataset did not allow
the estimation of underreporting by serotype/species.
The factors that mainly affect the completeness of surveil-
lance systems and should be further studied are related to
the health care system (lack of personnel, of technical sup-
port, etc.), the data providers (lack of interest or training,
etc.) or the surveillance system (long or complicated
reporting forms, lack of electronic reporting systems,
etc.) [26,27]. Results of this study were disseminated to the
hospitals accompanied with a request to all clinical doctors
to systematically notify salmonellosis and shigellosis cases
and to report possible problems of the reporting process.
Estimation of the diseases’ community incidence using
the hospitalisation rate of the diseases reported by other
European countries may not have been totally accurate;
however this approach was decided since a nation-wide
study on under-ascertainment of the two diseases is not
available. Published estimations of the foodborne diseases’
community incidence in Greece are based on travelers
[28,29] or data from other countries [30-32] and are sub-
ject to several biases. In addition, the available estimations
refer to past data and may be outdated and no longer
applicable [30]. Thus, we believe that the extrapolation of
the hospitalisation rate based on recent data from other
European countries with quite similar morbidity patterns
with Greece -though not the optimum method- leads to a
more accurate estimation than the already available.
Another limitation was that private hospitals were
not included in the estimation. Based on the literature,
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16% of total admissions, but a specific estimation for
salmonellosis and shigellosis cases is not available [33].
The range of the estimated community incidence of
salmonellosis, though wide, was compatible to estimations
from other European countries [34], higher than in Canada
[26], Australia [31], and Netherlands [34] and lower than
Poland [21].
Conclusions
The conducted C-RC study led to a quite accurate estima-
tion of the notification rates of salmonellosis and shigellosis
without the need to collect new data. Consequently, this is
deemed a tool that can be used for regular evaluation of
MNS and for assessing the effectiveness of correction
measures taken for the improvement of the system. How-
ever, the restrictions of C-RC studies should be kept in
mind given the fact that a third source for adjusting calcu-
lations is not available [35].
Differences in the notification rate by geographical
region and hospital can guide interventions for the im-
provement of notification.
Finally, for accurately estimating the community burden
of salmonellosis and shigellosis, a nation-wide study on
current underreporting and under-ascertainment rate of
the diseases is needed.
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